articleNature GeneticsSep 13, 2009Closed access

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

FTfor the Hepatitis C StudyVSVijayaprakash SuppiahMMMax MoldovanGAGolo AhlenstielTBThomas Berg

The University of Sydney · Westmead Institute · +13 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,816
total citations
FWCI
117.98
Percentile
100%
References
52
Citations per year

Authors

20

Topics & keywords

Keywords
  • Ribavirin
  • Interleukin 28B
  • Pegylated interferon
  • Hepatitis C virus
  • Hepatitis C
  • Virology
  • Immunology
  • Biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.